drugset / Trial / NCT02829346

Peri-articular Tranexamic Acid Injection in Total Knee Arthroplasty

NCT02829346

Phase 2 Completed 60 enrolled Thammasat University
RandomizedParallel-groupSingle-blindTreatment

Summary

This study evaluates the peri-articular tranexamic acid injection in total knee arthroplasty which is an alternative route of administration for blood loss reduction. Half of participants will receive intravenous tranexamic acid injection, while the other half will receive peri-articular tranexamic acid injection during total knee arthroplasty.

Timeline

Start
2012-10
Primary completion
2013-10
Completion
2013-10

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 750 mg Other

Indications